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Caenorhabditis elegans pharyngeal muscle development involves ceh-22, an NK-2 family homeobox gene related to genes controlling
heart development in other species. ceh-22 is the earliest known gene expressed in the pharyngeal muscles and is likely regulated directly by
factors specifying pharyngeal muscle fate. We have previously implicated the ceh-22 distal enhancer in initiating ceh-22 expression. Here we
analyze the distal enhancer using functional and comparative assays. The distal enhancer contains three subelements contributing additively
to its activity, and functionally important regulatory sequences are highly conserved in Caenorhabditis briggsae. One subelement, termed
DE3, is strongly active in the pharyngeal muscles, and we identified two short oligonucleotides (de199 and de209) contributing to DE3
activity. Multimerized de209 enhances transcription similarly to DE3 specifically in the pharyngeal muscles, suggesting it may be an
essential site regulating ceh-22. de209 binds the pan-pharyngeal Forkhead factor PHA-4 in vitro and responds to ectopic pha-4 expression in
vivo, suggesting that PHA-4 directly initiates ceh-22 expression through de209. Because de209 enhancer activity is primarily limited to the
pharyngeal muscles, we hypothesize that de209 also binds factors functioning with PHA-4 to specifically activate ceh-22 expression in
pharyngeal muscle.
D 2003 Elsevier Inc. All rights reserved.Keywords: C. elegans; Pharyngeal muscle; ceh-22; pha-4; C. briggsae; Gene regulationIntroduction
The mechanisms controlling heart specification and dif-
ferentiation are conserved in species as diverged as Dro-
sophila and humans. At the center of this mechanism are
NK-2 homeobox genes related to Drosophila tinman and the
vertebrate nkx2.5 genes (for review, see Cripps and Olson,
2002; Srivastava, 2001). These genes are expressed early in
a program of heart differentiation and play crucial roles in
specifying cardiac fate and in regulating cardiac gene
expression.
Nematodes do not have hearts. However, development of
the Caenorhabditis elegans pharynx involves the NK-2
family homeobox gene ceh-22. ceh-22 is one of the four
NK-2 homeobox genes in C. elegans, and it is exclusively
expressed in the pharyngeal muscles (Consortium, 1998;0012-1606/$ - see front matter D 2003 Elsevier Inc. All rights reserved.
doi:10.1016/j.ydbio.2003.10.015
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E-mail address: okkema@uic.edu (P.G. Okkema).Harfe and Fire, 1998; Okkema and Fire, 1994). ceh-22 is
necessary for normal pharyngeal muscle function and gene
expression (Okkema et al., 1997), and it can be functionally
replaced by the zebrafish nkx2.5 (Haun et al., 1998).
Together these results suggest that the mechanisms regulat-
ing nematode pharyngeal development share common fea-
tures with those regulating heart development in other
species.
The C. elegans pharynx is a rhythmically contracting
tube that functions in the digestive system to pump a
suspension of bacteria through a central lumen into the
gut. It consists of five very different cell types (muscles,
neurons, epithelial cells, secretory gland cells, and struc-
tural epithelial cells called marginal cells) (Albertson and
Thomson, 1976). The pharynx is produced from two
blastomeres called ABa and MS (Sulston et al., 1983),
which are specified by distinct genetic mechanisms (for
review, see Bowerman, 1998), and the pharyngeal primor-
dium forms about half-way through embryogenesis as a
compact group of undifferentiated cells surrounded by a
distinct basement membrane (Sulston et al., 1983). These
cells subsequently differentiate, and the pharynx undergoes
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before hatching. The pharynx increases in size during
postembryonic development, but there are no cell divisions
after formation of the pharyngeal primordium (Sulston et
al., 1983).
Formation of the pharyngeal primordium and differenti-
ation of all pharyngeal cell types require PHA-4, a FOXA
family Forkhead domain transcription factor (Horner et al.,
1998; Kalb et al., 1998; Mango et al., 1994). PHA-4 is
expressed in all pharyngeal cells (Horner et al., 1998; Kalb
et al., 1998), and it may directly regulate all genes expressed
in the pharynx (Gaudet and Mango, 2002). In the pharyn-
geal muscles, PHA-4 functions with CEH-22 to activate
expression of the pharyngeal muscle-specific myosin gene
myo-2 (Kalb et al., 1998; Okkema and Fire, 1994). Like-
wise, PHA-4 and CEH-22 both target an autoregulatory
enhancer believed to maintain ceh-22 expression in pharyn-
geal muscle (Gaudet and Mango, 2002; Kuchenthal et al.,
2001). However, little is known about how genes such as
ceh-22 are initially activated by PHA-4 in the early stages of
pharyngeal cell type differentiation.
ceh-22 is expressed exclusively in the pharyngeal
muscles, and it is the earliest known marker of pharyngeal
muscle differentiation (Okkema and Fire, 1994). ceh-22
expression begins shortly after the formation of the pharyn-
geal primordium at the bean stage of development (approx-
imately 380 min post first cleavage), and it is regulated at
the transcriptional level (Kuchenthal et al., 2001; Okkema
and Fire, 1994). The ceh-22 promoter is contained in the 1.9
kb intergenic region upstream of ceh-22, and two enhancers
in this promoter region contribute differently to ceh-22
expression (Kuchenthal et al., 2001). The proximal enhanc-
er, located just upstream of the gene, becomes active
exclusively in the pharyngeal muscles after the onset of
endogenous ceh-22 expression. It contains an autoregulatory
site targeted by CEH-22 and is likely to maintain ceh-22
expression. In contrast, the distal enhancer, located approx-
imately 1.4 kb upstream of the gene, becomes active in the
pharynx at the bean stage when endogenous ceh-22 expres-
sion initiates. Later the distal enhancer becomes more
broadly active in other pharyngeal cell types as well as
outside the pharynx in body wall muscles. A truncated ceh-
22 promoter lacking the distal enhancer becomes active only
after the onset of endogenous ceh-22 (Gaudet and Mango,
2002). We hypothesize that the distal enhancer is a crucial
regulatory sequence initiating ceh-22 expression in response
to signals specifying pharyngeal muscle fate (Kuchenthal et
al., 2001).
In this paper, we characterize the ceh-22 distal enhancer
using a combination of functional and comparative analy-
ses. This enhancer consists of three separable subelements,
which we call DE1, DE2, and DE3, with different cell type
specificities that contribute additively to distal enhancer
activity. DE3 is a potent pharyngeal muscle-specific en-
hancer, and it is strongly conserved in the related nema-
tode Caenorhabditis briggsae. Within DE3, we haveidentified two separate oligonucleotides termed de199
and de209 sufficient for pharyngeal enhancer activity.
These oligonucleotides display distinct cell type specific-
ities, but together recapitulate the activity of DE3. de209 is
necessary for DE3 enhancer activity and can specifically
activate gene expression in the pharyngeal muscles. de209
binds PHA-4 in vitro, and ectopic PHA-4 expression can
activate this enhancer outside the pharynx in vivo. We
hypothesize that ceh-22 expression is initiated by a com-
binatorial action of PHA-4 and other transcriptional acti-
vators, and repressors that recognize sequences within the
distal enhancer.Materials and methods
Plasmids and general methods for nucleic acid
manipulations
Standard methods were used to manipulate plasmid
DNAs and oligonucleotides (Ausubel, 1990). The distal
enhancerDlacZ fusion (pOK103.12) used to initiate this
analysis was described previously (Kuchenthal et al.,
2001). All enhancer constructs were assayed using the
Dpes-10DlacZ fusion vector pPD95.27 kindly provided by
Dr. Andrew Fire, Carnegie Institution of Washington (Sey-
doux and Fire, 1994). DE1, DE2, and DE3 fragments were
generated by PCR using primers with incorporated SphI or
XbaI restriction sites allowing ligation upstream of the
Dpes-10DlacZ reporter (DE1 primers: PO57 ACATG-
CATGCCGGATATAAACACTGA, PO58 GCTCTA-





these fragments were subsequently cloned upstream of
Dpes-10DlacZ using standard cloning techniques. Oligonu-
cleotides assayed for enhancer activity contained 5V non-
palindromic overhangs for ligation as head-to-tail concate-
nates into the StyI site of pPD95.27 as described previously
(Kuchenthal et al., 2001; Okkema and Fire, 1994; Thatcher
et al., 2001). Double stranded de199alt (PO415
CCTCTGTGTAGGTGGAGAAACGCACACACAAA/
PO416 GAGGTTTGTGTGTGCGTTTCTCCACCTA-
CACA) and de200alt (PO417 CCTCTGGACAAACAGA-
TAACGCGGCCGTATTT / PO418 GAGGAAA-
TACGGCCGCGTTATCTGTTTGTCCA) oligonucleotides
were ligated using complementary ends, end-filled using
T4 DNA polymerase, and cloned into the StuI site of
pPD95.27. Oligonucleotide enhancers were sequenced to
confirm the number and integrity of the inserts.
de199 and de209 sequences were deleted from DE3
using a modification of a procedure described in Xu and
Gong (1999). Briefly, the entire plasmid pOK125.25 was
amplified by inverse PCR using primers that anneal in DE3
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CAAGGAACAAGAAGT/PO268 CGCCTCGAGCA-
CAAAATGGATTCTAGAGGA) or de209 (PO269
GGAGATCTTGGATCCGCATGCAA/PO270 GGA-
GATCTTACCGTAATCTTTTTTGCTC). The PCR product
was recircularized using either XhoI (DE3(de199)) or BglII
(DE3(Dde209)) restriction sites present in the primers. The
DE3(DPHA-4) enhancer was constructed by inserting the
double-stranded oligonucleotide (PO610 AGCTTG-
CATGCGGATCCAAAAATACGGCCGCGTA/PO611
GATCTACGCGGCCGTATTTTTGGATCCGCATGCA) in-
to HindIII and BglII digested pOK151.06. The mutated
enhancers were sequenced and recloned into pPD95.27.
Fosmids containing Cb-ceh-22 were identified by hy-
bridizing a filter array of C. briggsae genomic DNA
(Genome Systems) with a ceh-22 cDNA probe, and the
BAC clone CB021D15 (accession number , AC099762)
containing these fosmids was identified and sequenced by
the Genome Sequencing Center (Washington University).
The Cb-ceh-22 promoter fragment containing the entire
intergenic region between Cb-ceh-22 and the upstream gene
Cb-twk-9 was amplified using primers PO419 (GCACTG-
CAGTCATTTGCTTCAACGTGG) and PO420Table 1
Cell type specificity of distal enhancer constructs
Enhancer Plasmid name n (number of Percentage of cells expr
cells scored)a
m1 m2 m3
Distal enhancerb pOK103.12 90 (504) 56 2 61
DE1b pOK125.19 49 (251) 3 0 25
DE2b pOK127.05 55 (225) 65 0 12
DE3b pOK125.25 143 (713) 1 1 28
DE1 + DE2b pOK125.15 66 (377) 67 2 11
DE2 + DE3b pOK125.21 95 (534) 74 0.4 21
DE1 + DE3b pOK130.01 39 (314) 0 0 28
DE1 + DE1b pOK130.03 439 (314) 2 0 32
DE3 + DE3b pOK130.05 139 (1435) 0 0 57
DE3 + DE3 pOK130.05 100 (450) 0 0 18
5Xde199 pOK138.05 104 (148) 0 5 6
6Xde199alt pOK165.16 81 (259) 0 3 5
5Xde209 pOK138.18 128 (287) 0 0 25
6Xde209alt pOK165.17 86 (236) 0.2 0 11
DE3 pOK125.25 100 (310) 0 0 13
DE3(Dde199) pOK151.01 100 (184) 0 0 7
DE3(Dde209) pOK151.06 42 (12) 0 0 1
1Xde199 + 1Xde209 pOK154.24 113 (456) 0 4 17
5Xde199 mut1 pOK142.01 43 (73) 0.4 2 4
5Xde199 mut2 pOK142.02 114 (360) 0.3 1 29
5Xde199 mut3 pOK142.03 81 (218) 0 4 8
5Xde199 mut4 pOK142.05 81 (438) 5 10 14
Data represent percentages of cells of individual cell types in (n) F1 transformants e
are noted below) as described in the text and Materials and methods and injected
expressing h-galactosidase were scored in F1 transformants.
a Total number of h-galactosidase positive cells in the pharynxes of (n) F1 transf
b These plasmids were not linearized before injection.(CCCCCGGGCCGATGCGATAGAAGGC), and inserted
into pPD21.28 (Fire et al., 1990) digested with XmaI and
PstI. Sequences of all plasmid constructs are available from
the authors.
Handling of nematodes and transformation assays
C. elegans were grown under standard conditions (Lewis
and Fleming, 1995). Expression of lacZ in F1 transformants
was assayed as previously described (Kuchenthal et al., 2001;
Okkema et al., 1993; Thatcher et al., 2001). Briefly, plasmid
DNAs were injected into the germ line of adult hermaphro-
dites (Mello and Fire, 1995), and F1 progeny was stained for
h-galactosidase activity as larvae and adults (Fire, 1992).
Most plasmids, with exceptions described in Table 1, were
injected as gel purified HindIII–SpeI fragments to minimize
background h-galactosidase expression in marginal cells
from enhancers in the plasmid backbone. Enhancer con-
structs were injected at 50–100 Ag/ml either with or without
25 Ag/ml egl-15DlacZ plasmid NH#307 (kindly provided by
C. Branda and M. Stern, Yale University).
Transgenic strains OK296, OK297, OK298 express lacZ
under the control of the C. briggsae ceh-22 promoter. Theseessing h-galactosidase in F1 transformants
m4 m5 m6 m7 m8 mc1 mc2 mc3
43 47 2 32 0 54 18 19
8 63 0 24 4 20 17 3
1 6 0 4 0 31 10 6
11 41 1 21 10 28 21 11
2 43 0 9 0 25 25 1
10 18 0 9 4 19 19 5
9 62 0 26 3 58 48 36
11 58 3 24 14 39 45 23
77 71 28 47 17 58 37 45
54 31 8 18 8 13 3 3
11 1 2 8 0.3 4 0.3 4
9 4 13 11 0 2 3 0.4
5 19 1 16 1 2 5 1
25 10 9 14 4 7 4 7
37 14 4 13 5 10 7 4
25 8 3 8 4 3 5 1
2 0 2 2 0 1 1 1
45 9 17 20 14 9 5 3
4 1 6 6 0 5 2 15
48 0 2 2 1 13 1 4
27 1 10 24 1 5 0.4 3
22 16 5 13 0 20 11 21
xpressing h-galactosidase. Each reporter plasmid was linearized (exceptions
alone into the germlines of adult hermaphrodites (P0). All pharyngeal cells
ormants.
Fig. 1. Location of the ceh-22 distal enhancer and subelements. (A) ceh-22
genomic organization numbered according to F29F11 sequence (GenBank
accession number Z73974). Gray boxes indicate ceh-22 coding exons. The
region upstream of the first exon is the complete intragenic region between
twk-9/F29F11.4 and ceh-22/F29F11.5 and is the ceh-22 promoter in this
study (bp 15626–17485). The distal enhancer (bp 15563–16049) and the
proximal enhancer (bp 16684–17467) defined by Kuchenthal et al. (2001)
are indicated. (B) Location of the DE1 (bp 15563–15691), DE2 (bp
15677–15902), and DE3 (bp 15931–16049) subelements of the distal
enhancer. (C) Positions of DE3 oligonucleotides examined for enhancer
activity as described in the text. These oligonucleotides contained 28 bp of
ceh-22 sequence and overlapped by 14 bp. The de199 and de209
oligonucleotides exhibiting pharyngeal enhancer activity are indicated as
thick bars. The locations of these oligonucleotides in F29F11 are indicated
in Table 2.
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generated by injecting plasmid pOK164.01 (25 Ag/ml) in
combination with pRF4 (100 Ag/ml) (Mello and Fire, 1995).
Ectopic expression of transcription factors
The effect of ectopic expression of pha-4 and elt-5 on the
activity of de209 was examined in F1 transformants as
previously described (Kalb et al., 2002; Kuchenthal et al.,
2001). Strain JM70 contains a chromosomally integrated
array bearing pJM92 for expressing pha-4 under the control
of the hsp16-2 promoter (Kalb et al., 1998), and strain
JR869 (a gift from M. Maduro and J. Rothman) contains an
extrachromosomal array expressing elt-5 under the control
of the hsp16-2 promoter. Transgenic JM70 and JR869 adult
hermaphrodites were injected with the plasmid pOK138.18
and allowed to produce progeny for 6–7 days at 16jC. The
F1 broods were subjected to two heat shocks for 2 h each at
33jC with an intervening 30 min recovery period. They
were then incubated 17–19 h at 25jC and stained to detect
h-galactosidase expression (Fire, 1992).
Gel mobility shift assays
PHA-4B protein (a gift from J. Kalb and J. McGhee) was
incubated in 20-Al binding reactions containing 25 mM
HEPES (pH 7.5), 50 mM KCl, 0.1 mM ZnSO4, 1 mM DTT,
0.2 mg/ml BSA, 10% glycerol, 0.1% NP-40, 50 ng/Al poly
dI/dC, 50 ng/Al poly dA/dT, 12.5 ng/Al protein, and 2500
cpm/Al de209 probe at room temperature for 20 min and
electrophoresed on a 5% non-denaturing acrylamide gel at
4jC. Labeled de209 was prepared by annealing oligonu-
cleotides PO209 (CAAGTGGACAAACAGATAACG-
CGGCCGTATTT ) a n d PO 2 1 0 ( CTTGAAA -
TACGGCCGCGTTATCTGTTTGTCCA), and end-filling
with the Klenow fragment of DNA Polymerase I in the
presence of a[32P]-dCTP (800 Ci/mmol). For competition
experiments, unlabeled de209mut1-1 was prepared by
annealing oligonucleotides PO275 (CAAGTGCCCGGG-
CAGATAACGCGGCCGTATTT) and PO276 (CTTGAAA-
TACGGCCGCGTTATCTGCCCGGGCA), while unlabeled
de209mut2 was prepared by annealing oligonucleotides
PO238 (CAAGTGGACAAAACTCGAACGCGGCCG-
TATTT) and PO239 (CTTGAAATACGGCCGCGTTC-
GAGTTTTGTCCA).Results and discussion
The distal enhancer is modular and contains multiple
functionally important sequences
The ceh-22 distal enhancer is a potent pharyngeal muscle
enhancer (Fig. 1A; (Kuchenthal et al., 2001)). In transgenic
C. elegans, it specifically activated frequent expression of a
Dpes-10DlacZ reporter gene in the ceh-22 expressing pha-ryngeal muscles (m1, m3, m4, m5, and m7) in an F1
expression assay (Fig. 2A, Table 1). Expression was also
sometimes observed in the pharyngeal marginal cells (Table
1), but this activity was due at least in part to vector
sequences, as assays with a fragment containing only the
distal enhancerDDpes-10DlacZ reporter resulted in de-
creased expression in the marginal cells (data not shown).
This pharyngeal expression pattern was similar to that
observed in lines stably transformed with this plasmid
(Kuchenthal et al., 2001), although occasional distal en-
hancer activity was observed in non-muscle cells in these
lines (Kuchenthal et al., 2001).
The distal enhancer is modular, and three fragments that
we call the DE1, DE2, and DE3 subelements (Fig. 1B)
retained pharyngeal muscle enhancer activity. DE1 and DE3
predominantly activated transcription in the m3, m4, m5,
and m7 pharyngeal muscles, while DE3 also activated
occasional expression in the pharyngeal–intestinal valve
and body wall muscle cells (Figs. 2B, D, Table 1, and data
not shown). Despite these similar activity patterns, DE1 and
Fig. 2. Three distinct subelements contribute to distal enhancer activity. DIC
micrographs showing h-galactosidase expression in adult F1 transformants
bearing ceh-22 distal enhancer fragments controlling expression of a Dpes-
10DlacZ reporter as described in the text. h-galactosidase activity is
localized in cell nuclei, and representative nuclei expressing h-galactosidase
are indicated (m indicates pharyngeal muscle; mc indicates pharyngeal
marginal cell). While DE1, DE2, DE3, and 2XDE3 are each effective
pharyngeal muscle enhancers when assayed in F1 transformants, they are
weakly active in stably transformed lines (data not shown). Similar
observations have been made using partial enhancers from myo-2 (Okkema,
and Fire, 1994; P. Okkema, unpublished).
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subelements are targeted by different regulatory factors. In
contrast, DE2 was highly active in the m1 pharyngeal
muscle cells (Fig. 2C, Table 1), a specialized syncytial cell
forming a thin sheet at the anterior of the pharynx (Albert-
son and Thomson, 1976). The m1 cells show no clear lineal
relationship (Sulston et al., 1983), suggesting that DE2
responds to signals that specify m1 cell fate rather than
lineal cues. We next assayed combinations of DE1, DE2,
and DE3 for enhancer activity, and found they generally
activated reporter gene expression in an additive rather than
a synergistic pattern (Table 1). DE3 was unique in that it
was a very strong pharyngeal muscle enhancer whenassayed in two copies (Table 1, Fig. 2E), and it was active
in all the larger pharyngeal muscles, including m6 in which
neither ceh-22 nor the intact distal enhancer was frequently
active (Kuchenthal et al., 2001; Okkema and Fire, 1994).
Taken together, these results suggest multiple developmen-
tal signals converge on the distal enhancer to regulate ceh-
22 expression, and DE3 is an essential target of factors
promoting pharyngeal muscle differentiation.
Functionally important sequences are conserved in C.
briggsae
Functional regulatory sequences are generally conserved
between C. elegans and the related nematode C. briggsae
(Kent and Zahler, 2000). To facilitate a comparative analysis
of the ceh-22 promoter, we identified clones containing C.
briggsae ceh-22 (see Materials and methods) and, in col-
laboration with the Genome Sequencing Center (GSC,
Washington University, St. Louis), sequenced the BAC
clone CB021D15 containing Cb-ceh-22 (GenBank acces-
sion number , AC099762). This BAC contains approximate-
ly 98 kb of sequence, which is highly syntenic with the C.
elegans ceh-22 region (data not shown).
We found that the Cb-ceh-22 promoter directed pharyn-
geal muscle expression in transgenic C. elegans. A Cb-ceh-
22DlacZ was first expressed weakly in the pharynx at the
bean stage, but expression was considerably increased by
the comma stage (Fig. 3A and data not shown). Expression
continued through the remainder of development and was
found in the m1, m3, m4, m5, and m7 pharyngeal muscle
cells, mc1 marginal cells, and occasionally in pharyngeal
neurons (Fig. 3B). Thus, the temporal and cell type speci-
ficity of Cb-ceh-22 promoter in C. elegans was similar to
Ce-ceh-22, although the frequency of lacZ expression was
lower and many transgenics exhibited mosaic expression
patterns. Thus, sequences regulating ceh-22 expression are
conserved between C. elegans and C. briggsae, although
one or more sequences required for optimal expression may
have diverged between the two species.
Alignment of the Ce-ceh-22 and Cb-ceh-22 promoters
revealed several regions of high sequence conservation, and
these predominantly localize to functionally identified
enhancers (Fig. 3C). Within the distal enhancer, the most
extended region of sequence identity included DE3 and
continued approximately 130 bp downstream of the distal
enhancer (Fig. 3D), suggesting that DE3 is part of a larger
regulatory element. Within the proximal enhancer, sequences
just upstream of the ceh-22 coding sequence and sequences
including an autoregulatory site are nearly identical in C.
briggsae (Kuchenthal et al., 2001). Several predicted binding
sites for PHA-4 (Gaudet and Mango, 2002) are conserved in
both the proximal and distal enhancers, while consensus
CEH-22 sites are clustered near the autoregulatory site in the
proximal enhancer (Fig. 3C) (Kuchenthal et al., 2001). The
location of conserved PHA-4 and CEH-22 sites in the
proximal enhancer is reminiscent of sites within the myo-2
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combined action of these factors may be a common mech-
anism for regulating pharyngeal muscle-specific genes.
Two distinct sequences within DE3 are sufficient to enhance
pharyngeal gene expression
DE3 retains strong pharyngeal muscle enhancer activity
very similar to the complete distal enhancer and is highly
conserved in C. briggsae, suggesting it is an important sitefor ceh-22 regulation. To identify short sequence elements
contributing to its activity, we assayed eight overlapping
oligonucleotides spanning DE3 for pharyngeal muscle en-
hancer activity (Fig. 1C). These oligonucleotides were
cloned in five copies upstream of Dpes-10DlacZ and
assayed for pharyngeal enhancer activity in F1 transform-
ants. Initially, these constructs were assayed together with
an egl-15DlacZ reporter, which is expressed in the hypo-
dermis but not in the pharynx (Table 2). This procedure
allowed us to recognize all transformants expressing h-
galactosidase and to determine the percentage of these
transformants expressing Dpes-10DlacZ in the pharynx
(Kuchenthal et al., 2001). Without any oligonucleotide,
the Dpes-10DlacZ reporter in pPD95.27 was expressed in
a small number of pharyngeal cells (generally one muscle or
marginal cell) in 20% of transformants, and constructs
containing most of the oligonucleotide multimers were
expressed at similar or lower frequency than the parental
vector (Table 2). In contrast, constructs containing either the
5Xde199 or 5Xde209 enhancers were expressed significant-
ly more frequently and in more cells in the pharynx than
Dpes-10DlacZ (Table 2). Enhancer activity of these oligo-
nucleotides depended on ceh-22 sequences, as enhancers
containing six copies of these oligonucleotides ligated using
a different linker sequence, 6Xde199alt and 6Xde209alt (see
Materials and methods), activated pharyngeal h-galactosi-
dase expression at a frequency nearly identical to the
original 5Xde199 and 5Xde209 enhancers (Table 2). Within
DE3, the de199 and de209 oligonucleotides are partially
conserved in C. briggsae, and the spacing between these
sequences is identical (Fig. 3D), suggesting that factors
binding them may interact in a spatially constrained manner.
We next examined cell type specificity of the de199 and
de209 multimer enhancers by assaying their activity withoutFig. 3. Functionally important ceh-22 promoter elements are conserved in
C. briggsae. (A, B) DIC micrographs showing transgenic C. elegans
expressing h-galactosidase under the control of the Cb-ceh-22 promoter.
(A) A comma stage embryo expressing h-galactosidase exclusively in the
cells within the pharyngeal primordium. (B) An adult showing expression
in m3, m4 pharyngeal muscle cells, mc1 marginal cells, and pharyngeal
neurons. (C) A dot-plot comparing ceh-22 promoter sequences from C.
elegans (horizontal axis) and C. briggsae (vertical axis). C. elegans ceh-22
is numbered according to F29F11 (GenBank accession number Z73974).
C. briggsae ceh-22 is numbered according to CB021D15 (accession
number AC099762). The positions of the enhancers described in the text
are shown below. de199 and de209 oligonucleotide enhancers are indicated
by white squares within DE3. pe39 oligonucleotide enhancer (Kuchenthal
et al., 2001) is shown as a white square within the proximal enhancer. Most
of the conserved sequences are located within the proximal and distal
enhancers as well as downstream of the distal enhancer. The positions of
conserved CEH-22 and PHA-4 consensus binding sites are shown as gray
and black arrowheads, respectively. A conserved PHA-4 site is located
within de209 and two conserved CEH-22 sites are located within pe39
(Kuchenthal et al., 2001). (D) A ClustalW alignment of the DE3 fragment
and conserved downstream sequences with the corresponding sequence in
the Cb-ceh-22 promoter. DE3 (shaded box) is highly conserved between the
two species. Positions of the de199 and de209 oligonucleotides and the
deletion in DE3(DPHA-4) are indicated.
Table 2













5Xde197 pOK138.04 7 (123) 15932–15959
5Xde199 pOK138.05 37 (74) 15945–15972
6Xde199alt pOK165.16 42 (229) 15945–15972
5Xde201 pOK138.06 19 (52) 15959–15986
5Xde203 pOK138.09 5 (92) 15973–16000
5Xde205 pOK138.13 3 (112) 15988–16015
5Xde207 pOK138.16 0 (68) 16004–16031
5Xde209 pOK138.18 87 (144) 16015–16042
6Xde209alt pOK165.17 80 (167) 16015–16042
5Xde211 pOK139.07 29 (72) 16029–16056
DE3 pOK125.25 38 (60)
DE3(Dde199) pOK151.01 26 (191)
DE3(Dde209) pOK151.06 9 (56)
DE3(DPHA-4) pOK185.62 7 (56)
1Xde199 pOK154.21 6 (82)
1Xde209 pOK154.22 12 (85)
1Xde199 + 1Xde209 pOK154.24 28 (194)
5Xde199 mut1 pOK142.01 31 (104)
5Xde199 mut2 pOK142.02 93 (110)
5Xde199 mut3 pOK142.03 26 (110)
5Xde199 mut4 pOK142.05 79 (120)
5Xde199 mut5 pOK142.06 6 (109)
None pPD95.27 20 (186)
None none 0 (18)
Each enhancer construct was assayed as a fusion to Dpes-10DlacZ.
Reporter plasmids were co-injected into the germline of adult hermaphro-
dites (P0) with the egl-15::lacZ fusion plasmid NH#307. The number of F1
transformants expressing h-galactosidase in the pharynx was divided by the
total number of transformants (n).
a Location of the oligonucleotide using the numbering scheme in the
F29F11 sequence (accession number Z73974).
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can activate transcription in the pharyngeal muscles, al-
though they exhibit distinct patterns of activity in other cell
types. 5Xde199 and 6Xde199alt activated reporter gene
expression more broadly than DE3 in most pharyngeal
muscles and in marginal cells, with occasional expression
in pharyngeal epithelial cells and in body wall muscles
(Table 1, Fig. 4A, and data not shown). In comparison,
5Xde209 and 6Xde209alt activated reporter expression in a
pattern similar to DE3 in the pharyngeal muscles, with
occasional expression in the m6 muscles, marginal cells,
and pharyngeal–intestinal valve cells (Table 1, Fig. 4B, and
data not shown). The parental Dpes-10DlacZ reporter in
pPD95.27 was occasionally expressed in posterior gut cells,
with < 0.25 h-galactosidase expressing pharyngeal cells–
transformant (data not shown).
To determine how de199 or de209 contribute to DE3
activity, we deleted these sequences and assayed enhancer
activity wild-type DE3 activated pharyngeal expression in
38% of the transformants (Table 2), and as described above,
this expression was predominantly in ceh-22 expressing
pharyngeal muscles and occasional pharyngeal intestinalvalve and body wall muscle cells (Table 1 and data not
shown). Deletion of de199 resulted in only a moderate
decrease in enhancer activity (Table 2—DE3(Dde199)),
and no change in cell type specificity (Table 1 and data
not shown). In contrast, deletion of de209 resulted in a
substantial decrease in enhancer activity (Table 2—
DE3(Dde209)), and this activity was specifically reduced
in the pharyngeal muscles and the pharyngeal–intestinal
valve cells (Table 1 and data not shown). To ask if de199
and de209 function together to activate gene expression, we
compared enhancer activity of a single copy of either de199
or de209 with an enhancer containing one copy of both
de199 and de209. In assays with the egl-15DlacZ co-
injection marker, the 1Xde199 and 1Xde209 enhancers
exhibited little or no pharyngeal enhancer activity (Table
2). In contrast, 1Xde199 + 1Xde209 exhibited more frequent
pharyngeal enhancer activity approaching that of the full
DE3 fragment (Table 2). In assays without egl-15DlacZ,
1Xde199 + 1Xde209 activated frequent reporter gene ex-
pression in the pharyngeal muscle cells and occasionally in
pharyngeal epithelial cells and marginal cells (Table 1, Fig.
4C, and data not shown). These data indicate that de209 is
required for DE3 pharyngeal enhancer activity, and the
combination of de209 and de199 activates transcription
similarly to intact DE3.
de199 contains distinct activating and repressing sites
We assayed enhancer activity of de199 derivatives
containing short substitutions (Fig. 5A), and found evi-
dence for multiple activating and repressing sites.
5Xde199mut5 exhibited dramatically reduced pharyngeal
enhancer activity when assayed with egl-15DlacZ (Table
2), indicating that this mutation affects an activator
binding site. In contrast, 5Xde199mut2 and 5Xde199mut4
exhibited increased pharyngeal enhancer activity (Table
2), indicating that these mutations affect repressor binding
sites. Compared to wild-type 5Xde199, 5Xde199mut2 and
5Xde199mut4 exhibited different effects on enhancer cell
type specificity. When assayed alone, 5Xde199mut2 acti-
vated lacZ expression in a similar pattern of cells as wild-
type 5Xde199, although expression was more frequent in
the m3 and m4 pharyngeal muscles and less frequent in
body wall muscles (Table 1 and data not shown).
5Xde199mut4 activated transcription more frequently than
wild-type 5Xde199 in most pharyngeal cell types includ-
ing the muscles and epithelial cells, as well as pharyngeal
neurons and the pharyngeal–intestinal valve cells, where
5Xde199 activity was not observed (Table 1, Fig. 4D, and
data not shown). Therefore, two repressors with different
functions may bind de199.
PHA-4 targets de209 in vitro and in vivo
The pan-pharyngeal factor PHA-4 is believed to regulate
all genes expressed in the pharynx (Gaudet and Mango,
Fig. 5. Sequence of de199 and de209 oligonucleotides. (A, B) Sequences of
wild-type and mutant de199 and de209 oligonucleotides discussed in text.
The wild-type oligonucleotide sequence is shown in both strands, while the
mutant sequences are shown only in the top strand with the altered bases
indicated in lower case. de209 contains two possible binding sites for PHA-
4 (boxed). Site 1 is a perfect match to the predicted TRTTKRY consensus
(Gaudet and Mango, 2002) on the bottom strand, while site 2 is an
incomplete match, with a C instead of a T at position 4. Site 1 is altered
from this consensus in de209mut1-1, while both sites are disrupted in
de209mut2. (C) An electrophoretic mobility shift assay indicating PHA-4
binds specifically to de209 in vitro. PHA-4 was incubated with 32P-labeled
de209 either in the absence (lane 2) or the presence (lanes 3–11) of the
indicated competitors. Unlabeled competitors were present in a 10-fold
(lanes 3, 6, 9), 50-fold (lanes 4, 7, 10), or 250-fold (lanes 5, 8, 11) excess.
Fig. 4. Two distinct oligonucleotide enhancers contribute to DE3 activity.
DIC micrographs showing h-galactosidase expression in adult F1 trans-
formants bearing DE3 oligonucleotide enhancer constructs described in the
text. Representative cell types are labeled (m—pharyngeal muscle; mc—
marginal cell; P– I valve—pharyngeal– intestinal valve cell; bwm—body
wall muscle). (A) An adult expressing Dpes-10DlacZ reporter under the
control of 5Xde199. (B) An adult expressing Dpes-10DlacZ reporter under
the control of 5Xde209. These images show most of the cell types in which
de199 and de209 are active. On average, 3.3 (de199) and 2.4 (de209) cells
per transformant express h-galactosidase. Similar expression patterns were
observed using 6Xde199alt and 6Xde209. (C) An adult expressing a Dpes-
10DlacZ reporter controlled by an enhancer construct containing a single
copy de199 and de209. (D) An adult expressing a Dpes-10DlacZ reporter
controlled by the de199mut4 oligonucleotide. Activity is increased in
pharyngeal muscles, marginal cells, epithelial cells, and in tissues outside
the pharynx.
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differentially regulates genes expressed in specific pharyn-
geal cell types. This situation is best understood in the later
stages of pharyngeal muscle differentiation, where the
pharyngeal muscle-specific myosin gene myo-2 is activated
by the combined activities of PHA-4 and CEH-22 (Kalb et
al., 1998; Okkema and Fire, 1994). Likewise, maintained
expression of ceh-22 may involve both PHA-4 and CEH-22
(Gaudet and Mango, 2002; Kuchenthal et al., 2001). How-
ever, we do not know if PHA-4 directly initiates ceh-22
expression, and if so, how ceh-22 is specifically activated in
the pharyngeal muscles.
DE3 contains two conserved sites similar to the predicted
PHA-4 consensus TRTTKRY within de209 (Gaudet andMango, 2002) (Fig. 5B). We asked if PHA-4 recognized
these sites in vitro, and found it bound de209 (Fig. 5C). A
mutation in de209mut1-1 disrupting PHA-4 site 1 did not
eliminate binding, while a mutation in de209mut2 disrupt-
ing both sites completely eliminated binding (Figs. 5B, C).
These results indicate that PHA-4 binding is specific,
although we cannot distinguish whether it binds both sites
or only site 2. PHA-4 binding appears essential for activity
of the DE3 enhancer, as deletion of these sites resulted in a
Table 3







N2 none 5 (57)
JM70a PHA-4 42 (81)
JR869b ELT-5 12 (100)
Each reporter plasmid was injected into the germline of adult hermaph-
rodites (P0) of the indicated strains. F1 transformants recognized because of
pharyngeal h-galactosidase expression were scored for expression outside
the pharynx.
a A chromosomally integrated line expressing pha-4 under the control of
the hsp16-2 promoter (Kalb et al., 1998; Stringham et al., 1992).
b An extrachromosomal line expressing elt-5 under the control of the hsp16-
2 promoter (Stringham et al., 1992). Data was normalized for the
percentage of progeny segregating the extrachromosomal array.
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DE3(DPHA-4)).
Ectopic pha-4 expression could also activate the de209
enhancer in vivo. Expression of pha-4 using a heat shock
promoter resulted in a large increase in the percent trans-
formants expressing 5Xde209DDpes-10DlacZ outside the
pharynxwhen compared to wild-typeworms (Table 3).While
de209 also contains a consensus GATA family factor binding
site (Ko and Engel, 1993; Merika and Orkin, 1993), we found
that ectopic expression of the ELT-5 GATA factor resulted in
only a weak increase in ectopic 5Xde209DDpes-10DlacZ
expression. Interestingly, ectopic pha-4 only activated the
5Xde209 enhancer only in body wall muscles, despite the fact
the heat shock promoter is active in many C. elegans tissues
(Stringham et al., 1992). A similar restriction to body wall
muscle was observed when ectopic ceh-22 was used to
activate a responsive reporter (Kuchenthal et al., 2001),
suggesting that factors functioning in combination with
PHA-4 and CEH-22 are also present in body wall muscle
cells.
Together these results suggest that PHA-4 activates
ceh-22 expression directly through de209, and that other
factors binding de209 function with PHA-4 to specifically
activate ceh-22 in the pharyngeal muscles. What factors
might function with PHA-4 to activate ceh-22 expression?
The GATA factor site in de209 overlaps the non-consen-
sus PHA-4 site, and Forkhead and GATA factors have
been suggested to function together in other systems to
provide a permissive context for gene activation (Zaret,
1999). C. elegans contains 11 GATA factor genes, and
while the de209 enhancer is not activated by ectopic ELT-
5, it could be targeted by other GATA factors. The MED-
1 and MED-2 GATA factors are expressed early and are
required for pharynx produced by the EMS blastomere
(Maduro et al., 2001), and they could directly regulate
ceh-22 in EMS-derived pharyngeal muscles. However,
de209 is also active in ABa-derived pharyngeal muscles,
suggesting that other factors must also target de209.Likewise, factors bound to de199 and other sites in the
distal enhancer could function with PHA-4 to activate
ceh-22 expression.
A common feature of C. elegans ceh-22, Drosophila
tinman, and vertebrate Nkx2-5 is that they are each
expressed early in the myogenic program of muscles that
do not express MyoD family factors (Cripps and Olson,
2002; Harvey, 1996). Are these genes expressed in re-
sponse to common signals specifying the fate of these
muscle types? Our current understanding suggests that the
answer is no. BMP-like signals are important for devel-
opment of both the Drosophila and vertebrate heart, and
these signals directly regulate Drosophila tinman and
murine Nkx2-5 (Lien et al., 2002; Sparrow et al., 2000;
Xu et al., 1998). In contrast, mutations affecting known
BMP-like signaling in C. elegans result in no pharyngeal
defects during embryogenesis (for review, see Patterson
and Padgett, 2000), and we have observed no effect of
loss of these signaling pathways on activity of the ceh-22
promoter (L. Beaster-Jones and P. Okkema, unpublished).
No consensus Smad binding sites (Johnson et al., 1999;
Thatcher et al., 1999; Zawel et al., 1998) conserved
between C. elegans and C. briggsae are found in DE3
or the downstream conserved region. GATA factors sites
are also essential for activity of the conserved AR2
enhancer in the mouse and Xenopus Nkx2-5 genes (Searcy
et al., 1998; Sparrow et al., 2000). As discussed above,
while a GATA site is present in the ceh-22 distal enhanc-
er, none of the C. elegans GATA factors appear to be
present in all ceh-22 expressing cells. Finally, wingless/
Wnt signaling has also be shown to regulate tinman and
murine Nkx2-5 (Marvin et al., 2001; Pandur et al., 2002;
Park et al., 1996; Schneider and Mercola, 2001). Howev-
er, pharyngeal defects have not been described for C.
elegans Wnt pathway mutants (for review, see Korswagen,
2002).
Instead, we show here that the Forkhead factor PHA-4
is likely involved in initiating ceh-22 expression. PHA-4 is
one of approximately 20 predicted Forkhead domain
proteins (Pfam motif PF00250) in C. elegans and is most
closely related to Drosophila Forkhead and the vertebrate
HNF-3 proteins (Horner et al., 1998; Kalb et al., 1998).
There is no evidence that these or other Forkhead domain
proteins are required for tinman or Nkx2-5 expression.
Although these factors are co-expressed in pharyngeal
endoderm in mouse, an HNF-3 consensus binding site in
the phylogenetically conserved murine nkx2-5 AR2 en-
hancer is not required for enhancer activity either in
pharynx or heart (Lien et al., 2002).Acknowledgments
This work was supported by a Public Health Service
grant GM53996 from the National Institute of General
Medical Sciences. We are grateful to Andrew Fire, Jim
T. Vilimas et al. / Developmental Biology 266 (2004) 388–398 397McGhee, John Kalb, Joel Rothman, and Morris Maduro
for providing some strains and reagents used in this work.
Some nematode strains used in this work were provided
by the Caenorhabditis Genetics Center, which is funded
by the NIH National Center for Research Resources
(NCRR). We are indebted to Muno Sekhon and the
Genome Sequencing Center at Washington University, St.
Louis, for identification of BAC clones and communica-
tion of DNA sequence data before publication. We are
also grateful to Matthew Schau, Tony Fernandez, and
Laura Beaster-Jones for comments on this manuscript,
and to the colleagues in the LMB for advice during this
work.References
Albertson, D.G., Thomson, J.N., 1976. The pharynx of Caenorhabditis
elegans. Philos. Trans. R. Soc. Lond., B Biol. Sci. 275, 299–325.
Ausubel, F.M., 1990. Current protocols in molecular biology. Greene Pub.
Associates and Wiley-Interscience: J. Wiley, New York.
Bowerman, B., 1998. Maternal control of pattern formation in early Cae-
norhabditis elegans embryos. Curr. Top. Dev. Biol. 39, 73–117.
Consortium, 1998. Genome sequence of the nematode C. elegans: a plat-
form for investigating biology. The C. elegans sequencing consortium.
Science 282, 2012–2018.
Cripps, R.M., Olson, E.N., 2002. Control of cardiac development by an
evolutionarily conserved transcriptional network. Dev. Biol. 246,
14–28.
Fire, A., 1992. Histochemical techniques for locating Escherichia coli beta-
galactosidase activity in transgenic organisms. Genet. Anal.: Tech.
Appl. 9, 151–158.
Fire, A., Harrison, S.W., Dixon, D., 1990. A modular set of lacZ fusion
vectors for studying gene expression in Caenorhabditis elegans. Gene
93, 189–198.
Gaudet, J., Mango, S.E., 2002. Regulation of organogenesis by the Caeno-
rhabditis elegans FoxA protein PHA-4. Science 295, 821–825.
Harfe, B.D., Fire, A., 1998. Muscle and nerve-specific regulation of a novel
NK-2 class homeodomain factor in Caenorhabditis elegans. Develop-
ment 125, 421–429.
Harvey, R.P., 1996. NK-2 homeobox genes and heart development. Dev.
Biol. 178, 203–216.
Haun, C., Alexander, J., Stainier, D.Y., Okkema, P.G., 1998. Rescue of
Caenorhabditis elegans pharyngeal development by a vertebrate heart
specification gene. Proc. Natl. Acad. Sci. U. S. A. 95, 5072–5075.
Horner, M.A., Quintin, S., Domeier, M.E., Kimble, J., Labouesse, M.,
Mango, S.E., 1998. pha-4, an HNF-3 homolog, specifies pharyngeal
organ identity in Caenorhabditis elegans. Genes Dev. 12, 1947–1952.
Johnson, K., Kirkpatrick, H., Comer, A., Hoffmann, F.M., Laughon, A.,
1999. Interaction of Smad complexes with tripartite DNA-binding sites.
J. Biol. Chem. 274, 20709–20716.
Kalb, J.M., Lau, K.K., Goszczynski, B., Fukushige, T., Moons, D., Okke-
ma, P.G., McGhee, J.D., 1998. pha-4 is Ce-fkh-1, a fork head/HNF-
3alpha,beta,gamma homolog that functions in organogenesis of the C.
elegans pharynx. Development 125, 2171–2180.
Kalb, J.M., Beaster-Jones, L., Fernandez, A.P., Okkema, P.G., Goszczyn-
ski, B., McGhee, J.D., 2002. Interference between the PHA-4 and PEB-
1 transcription factors in formation of the Caenorhabditis elegans phar-
ynx. J. Mol. Biol. 320, 697–704.
Kent, W.J., Zahler, A.M., 2000. Conservation, regulation, synteny, and
introns in a large-scale C. briggsae–C. elegans genomic alignment.
Genome Res. 10, 1115–1125.
Ko, L.J., Engel, J.D., 1993. DNA-binding specificities of the GATA tran-
scription factor family. Mol. Cell. Biol. 13, 4011–4022.Korswagen, H.C., 2002. Canonical and non-canonical Wnt signaling path-
ways in Caenorhabditis elegans: variations on a common signaling
theme. BioEssays 24, 801–810.
Kuchenthal, C.A., Chen, W., Okkema, P.G., 2001. Multiple enhancers
contribute to expression of the NK-2 homeobox gene ceh-22 in C.
elegans pharyngeal muscle. Genesis 31, 156–166.
Lewis, J.A., Fleming, J.T., 1995. Basic culture methods. In: Biology,
M.I.C. (Ed.), Caenorhabditis elegans: Modern Biological Analysis of
an Organism, vol. 48. Academic Press, San Diego, CA, pp. 4–30.
Lien, C.L., McAnally, J., Richardson, J.A., Olson, E.N., 2002. Cardiac-
specific activity of an Nkx2-5 enhancer requires an evolutionarily con-
served Smad binding site. Dev. Biol. 244, 257–266.
Maduro, M.F., Meneghini, M.D., Bowerman, B., Broitman-Maduro, G.,
Rothman, J.H., 2001. Restriction of mesendoderm to a single blasto-
mere by the combined action of SKN-1 and a GSK-3beta homolog is
mediated by MED-1 and -2 in C. elegans. Mol. Cell 7, 475–485.
Mango, S.E., Lambie, E.J., Kimble, J., 1994. The pha-4 gene is required to
generate the pharyngeal primordium of Caenorhabditis elegans. Devel-
opment 120, 3019–3031.
Marvin, M.J., Di Rocco, G., Gardiner, A., Bush, S.M., Lassar, A.B., 2001.
Inhibition of Wnt activity induces heart formation from posterior mes-
oderm. Genes Dev. 15, 316–327.
Mello, C., Fire, A., 1995. DNA transformation. In: Epstein, H.F., Shakes,
D.C. (Eds.), Caenorhabditis elegans: Modern Biological Analysis of an
Organism, vol. 48. Academic Press, San Diego, CA, pp. 451–482.
Merika, M., Orkin, S.H., 1993. DNA-binding specificity of GATA family
transcription factors. Mol. Cell. Biol. 13, 3999–4010.
Okkema, P.G., Fire, A., 1994. The Caenorhabditis elegans NK-2 class
homeoprotein CEH-22 is involved in combinatorial activation of gene
expression in pharyngeal muscle. Development 120, 2175–2186.
Okkema, P.G., Harrison, S.W., Plunger, V., Aryana, A., Fire, A., 1993.
Sequence requirements for myosin gene expression and regulation in
Caenorhabditis elegans. Genetics 135, 385–404.
Okkema, P.G., Ha, E., Haun, C., Chen, W., Fire, A., 1997. The Caeno-
rhabditis elegans NK-2 homeobox gene ceh-22 activates pharyngeal
muscle gene expression in combination with pha-1 and is required for
normal pharyngeal development. Development 124, 3965–3973.
Pandur, P., Lasche, M., Eisenberg, L.M., Kuhl, M., 2002. Wnt-11 activa-
tion of a non-canonical Wnt signalling pathway is required for cardio-
genesis. Nature 418, 636–641.
Park, M., Wu, X., Golden, K., Axelrod, J.D., Bodmer, R., 1996. The wing-
less signaling pathway is directly involved in Drosophila heart develop-
ment. Dev. Biol. 177, 104–116.
Patterson, G.I., Padgett, R.W., 2000. TGF beta-related pathways. Roles in
Caenorhabditis elegans development. Trends Genet. 16, 27–33.
Schneider, V.A., Mercola, M., 2001. Wnt antagonism initiates cardiogene-
sis in Xenopus laevis. Genes Dev. 15, 304–315.
Searcy, R.D., Vincent, E.B., Liberatore, C.M., Yutzey, K.E., 1998. A GATA-
dependent nkx-2.5 regulatory element activates early cardiac gene ex-
pression in transgenic mice. Development 125, 4461–4470.
Seydoux, G., Fire, A., 1994. Soma-germline asymmetry in the distributions
of embryonic RNAs in Caenorhabditis elegans. Development 120,
2823–2834.
Sparrow, D.B., Cai, C., Kotecha, S., Latinkic, B., Cooper, B., Towers, N.,
Evans, S.M., Mohun, T.J., 2000. Regulation of the tinman homologues
in Xenopus embryos. Dev. Biol. 227, 65–79.
Srivastava, D., 2001. Genetic assembly of the heart: implications for con-
genital heart disease. Annu. Rev. Physiol. 63, 451–469.
Stringham, E.G., Dixon, D.K., Jones, D., Candido, E.P., 1992. Temporal and
spatial expression patterns of the small heat shock (hsp16) genes in trans-
genic Caenorhabditis elegans. Mol. Biol. Cell 3, 221–233.
Sulston, J.E., Schierenberg, E., White, J.G., Thomson, J.N., 1983. The
embryonic cell lineage of the nematode Caenorhabditis elegans. Dev.
Biol. 100, 64–119.
Thatcher, J.D., Haun, C., Okkema, P.G., 1999. The DAF-3 Smad binds
DNA and represses gene expression in the Caenorhabditis elegans
pharynx. Development 126, 97–107.
T. Vilimas et al. / Developmental Biology 266 (2004) 388–398398Thatcher, J.D., Fernandez, A.P., Beaster-Jones, L., Haun, C., Okkema, P.G.,
2001. The Caenorhabditis elegans peb-1 gene encodes a novel DNA-
binding protein involved in morphogenesis of the pharynx, vulva, and
hindgut. Dev. Biol. 229, 480–493.
Xu, Y., Gong, Z., 1999. Adaptation of inverse PCR to generate an internal
deletion. BioTechniques 26, 639–641.
Xu, X., Yin, Z., Hudson, J.B., Ferguson, E.L., Frasch, M., 1998. Smad
proteins act in combination with synergistic and antagonistic regulatorsto target Dpp responses to the Drosophila mesoderm. Genes Dev. 12,
2354–2370.
Zaret, K., 1999. Developmental competence of the gut endoderm: genetic
potentiation by GATA and HNF3/fork head proteins. Dev. Biol. 209,
1–10.
Zawel, L., Dai, J.L., Buckhaults, P., Zhou, S., Kinzler, K.W., Vogelstein,
B., Kern, S.E., 1998. Human Smad3 and Smad4 are sequence-specific
transcription activators. Mol. Cell 1, 611–617.
